Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review

por Fiteni, Frédéric, Anota, Amélie, Westeel, Virginie, Bonnetain, Franck
Publicado en BMC Cancer (2016)

Clinical Relevance of Routine Monitoring of Patient-reported Outcomes Versus Clinician-reported Outcomes in Oncology

por FITENI, FREDERIC, CUENANT, ALICE, FAVIER, MIREILLE, COUSIN, CHRISTELLE, HOUEDE, NADINE
Publicado en In Vivo (2019)

Health-related quality of life as an endpoint in oncology phase I trials: a systematic review

por Fiteni, Frédéric, Ray, Isabelle Le, Ousmen, Ahmad, Isambert, Nicolas, Anota, Amélie, Bonnetain, Franck
Publicado en BMC Cancer (2019)

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review

por Fiteni, Frédéric, Nguyen, Thierry, Vernerey, Dewi, Paillard, Marie-Justine, Kim, Stefano, Demarchi, Martin, Fein, Francine, Borg, Christophe, Bonnetain, Franck, Pivot, Xavier
Publicado en Cancer Med (2014)

The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomas

por Kim, Stefano, Fiteni, Frederic, Paget-Bailly, Sophie, Ghiringhelli, François, Lakkis, Zaher, Jary, Marine, Fein, Francine, Bonnetain, Franck, Mariette, Christophe, Borg, Christophe
Publicado en J Hematol Oncol (2015)

Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for qual...

por Anota, Amélie, Hamidou, Zeinab, Paget-Bailly, Sophie, Chibaudel, Benoist, Bascoul-Mollevi, Caroline, Auquier, Pascal, Westeel, Virginie, Fiteni, Frederic, Borg, Christophe, Bonnetain, Franck
Publicado en Qual Life Res (2013)

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study

por CAUBET, MATTHIEU, DOBI, ERION, POZET, ASTRID, ALMOTLAK, HAMADI, MONTCUQUET, PHILIPPE, MAURINA, TRISTAN, MOUILLET, GUILLAUME, N'GUYEN, THIERRY, STEIN, ULRICH, THIERY-VUILLEMIN, ANTOINE, FITENI, FREDERIC
Publicado en Mol Clin Oncol (2015)

Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer

por Musoro, Jammbe Z, Coens, Corneel, Fiteni, Frederic, Katarzyna, Pogoda, Cardoso, Fatima, Russell, Nicola S, King, Madeleine T, Cocks, Kim, Sprangers, Mirjam Ag, Groenvold, Mogens, Velikova, Galina, Flechtner, Hans-Henning, Bottomley, Andrew
Publicado en JNCI Cancer Spectr (2019)

Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy

por Fiteni, Frédéric, Jary, Marine, Monnien, Franck, Nguyen, Thierry, Beohou, Eric, Demarchi, Martin, Dobi, Erion, Fein, Francine, Cleau, Denis, Fratté, Serge, Nerich, Virginie, Bonnetain, Franck, Pivot, Xavier, Borg, Christophe, Kim, Stefano
Publicado en BMC Gastroenterol (2014)

Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma

por Fiteni, Frédéric, Paget‐Bailly, Sophie, Messager, Mathieu, N'Guyen, Thierry, Lakkis, Zaher, Mathieu, Pierre, Lamfichekh, Najib, Picard, Alain, Benzidane, Bilell, Cléau, Denis, Bonnetain, Franck, Borg, Christophe, Mariette, Christophe, Kim, Stefano
Publicado en Cancer Med (2016)